Quanta, Inc. (QNTA) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
QNTA representa a Quanta, Inc., una empresa del sector Consumer Defensive con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 50/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 18 mar 2026Quanta, Inc. (QNTA) Descripción General del Negocio al Consumidor
Quanta, Inc. operates in the consumer wellness sector, providing pharmaceutical-grade products, clinical evidence-based nutraceuticals, and contract research services. The company utilizes patented polarization technology in its offerings, targeting pain relief, beauty, and general wellness markets, while facing competition from established players.
Tesis de Inversión
Quanta, Inc. presents a high-risk, high-reward investment opportunity within the consumer wellness sector. The company's reliance on patented polarization technology and contract research services could drive growth if successfully commercialized. However, the company's negative profit margin of -1312.4% and small market capitalization of $0.00B highlight significant financial challenges. Key value drivers include successful product development and market penetration in the pain relief, beauty, and general wellness categories. Upcoming catalysts involve securing additional contract research agreements and expanding distribution channels. Potential risks include intense competition, limited financial resources, and the need for further clinical validation of its technology. Investors should carefully consider the company's financial position and execution risks before investing.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Gross Margin of 78.7% indicates strong potential for profitability if sales volume increases.
- Negative Profit Margin of -1312.4% reflects significant operational losses and the need for improved cost management.
- Market Cap of $0.00B signifies a micro-cap company with high growth potential but also high risk.
- The company's Beta of 1.68 suggests higher volatility compared to the overall market.
- Founded in 2016, Quanta is a relatively young company in the competitive consumer wellness market.
Competidores y Pares
Fortalezas
- Patented polarization technology.
- Contract research service offerings.
- Focus on pharmaceutical-grade products.
- Potential for innovation in the consumer wellness market.
Debilidades
- Small company size with limited resources.
- Negative profit margin and financial instability.
- Limited brand recognition and market presence.
- Reliance on a small number of employees.
Catalizadores
- Upcoming: Potential new contract research agreements with pharmaceutical or nutraceutical companies.
- Upcoming: Launch of new consumer wellness products utilizing patented polarization technology.
- Ongoing: Expansion of e-commerce platform and direct-to-consumer sales.
- Ongoing: Exploration of strategic partnerships with established distributors and retailers.
Riesgos
- Potential: Intense competition from larger, more established companies in the consumer wellness market.
- Potential: Limited financial resources and the need for additional funding.
- Potential: Regulatory hurdles and compliance requirements for pharmaceutical and nutraceutical products.
- Ongoing: Negative profit margin and financial instability.
- Ongoing: Dependence on patented polarization technology and the risk of technological obsolescence.
Oportunidades de crecimiento
- Expansion of Contract Research Services: Quanta can leverage its research and development capabilities to secure additional contract research agreements with pharmaceutical and nutraceutical companies. The global contract research organization (CRO) market is projected to reach $79.3 billion by 2027, offering significant growth potential for Quanta. Timeline: Ongoing.
- Product Line Expansion: Quanta can introduce new products within the pain relief, beauty, and general wellness categories, leveraging its patented polarization technology. The global pain relief market is expected to reach $11.3 billion by 2028. Successful product launches can drive revenue growth and market share gains. Timeline: 1-2 years.
- Strategic Partnerships: Quanta can form strategic partnerships with established distributors and retailers to expand its market reach and distribution channels. Collaborations with major retailers can provide access to a wider customer base and increase brand visibility. Timeline: Ongoing.
- E-commerce Channel Development: Quanta can invest in its e-commerce platform to drive direct-to-consumer sales and improve customer engagement. The global e-commerce market is experiencing rapid growth, providing opportunities for Quanta to expand its online presence and reach new customers. Timeline: 6-12 months.
- International Market Expansion: Quanta can explore opportunities to expand its operations into international markets, particularly in regions with growing demand for consumer wellness products. Entering new markets can diversify revenue streams and reduce reliance on the domestic market. Timeline: 2-3 years.
Oportunidades
- Expansion of contract research services.
- New product development and market penetration.
- Strategic partnerships with established distributors.
- Growth in the consumer wellness market.
Amenazas
- Intense competition from larger companies.
- Regulatory hurdles and compliance requirements.
- Economic downturn and reduced consumer spending.
- Technological obsolescence.
Ventajas competitivas
- Patented Polarization Technology: Provides a unique selling proposition and potential competitive advantage.
- Contract Research Services: Offers a diversified revenue stream and opportunities for collaboration.
- Focus on Pharmaceutical-Grade Products: Targets a higher-margin segment of the consumer wellness market.
Acerca de QNTA
Founded in 2016 and headquartered in Burbank, California, Quanta, Inc. is an applied science company focused on the development, production, and distribution of consumer wellness products. The company operates within the household and personal products industry, offering a range of pharmaceutical, nutraceutical, topical relief, and cosmetic products. Quanta's business model encompasses contract research services, including research, development, and production of pharmaceutical-grade products, as well as clinical evidence-based nutraceuticals utilizing patented polarization technology. Quanta manufactures and distributes consumer wellness products targeting pain relief, beauty, and general wellness. The company's patented polarization technology is a key differentiator in its nutraceutical offerings. While relatively young, Quanta seeks to establish itself through innovation and contract research services, aiming to capture market share in the competitive consumer wellness landscape. The company's small size, with only 4 employees, indicates an early stage of development and a focus on leveraging its technology and research capabilities.
Qué hacen
- Develops pharmaceutical-grade products.
- Creates clinical evidence-based nutraceuticals.
- Manufactures topical relief products.
- Produces cosmetic products.
- Offers contract research services to other companies.
- Utilizes patented polarization technology in its products.
- Distributes consumer wellness products.
Modelo de Negocio
- Generates revenue through the sale of pharmaceutical, nutraceutical, topical relief, and cosmetic products.
- Earns income from contract research services provided to other companies.
- Utilizes patented polarization technology to create differentiated products.
- Focuses on the consumer wellness market.
Contexto de la Industria
Quanta, Inc. operates in the competitive household and personal products industry, which is characterized by established players and evolving consumer preferences. The global wellness market is experiencing growth, driven by increased health awareness and demand for natural and innovative products. Quanta's focus on pharmaceutical-grade products and patented polarization technology positions it within the higher-margin segments of the market. However, the company faces competition from larger, more established companies with greater resources and brand recognition. Key trends include personalized wellness solutions and e-commerce distribution.
Clientes Clave
- Consumers seeking pain relief products.
- Individuals interested in beauty and cosmetic products.
- Customers looking for general wellness solutions.
- Pharmaceutical and nutraceutical companies seeking contract research services.
Finanzas
Gráfico e información
Precio de la acción de Quanta, Inc. (QNTA): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Lows On Wednesday
· 25 sept 2019
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para QNTA.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para QNTA.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de QNTA en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Arthur G. Mikaelian
CEO
Arthur G. Mikaelian serves as the CEO of Quanta, Inc., leading a small team of 4 employees. Information regarding his detailed career history and educational background is not available in the provided data. However, as CEO, he is responsible for the overall strategic direction and operational management of the company, focusing on the development and commercialization of Quanta's pharmaceutical, nutraceutical, and cosmetic products.
Historial: Due to the limited information available, Arthur G. Mikaelian's track record at Quanta, Inc. cannot be comprehensively assessed. However, as the CEO since 2016, he has overseen the company's development and launch of products utilizing patented polarization technology. Further information is needed to evaluate his specific achievements and strategic decisions.
Información del mercado OTC de QNTA
The OTC Other tier represents the lowest tier of the OTC market, indicating that Quanta, Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available and may be subject to greater regulatory scrutiny. Trading on the OTC Other tier carries higher risks compared to exchanges like the NYSE or NASDAQ due to less stringent listing standards and potentially lower liquidity.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Potential for price manipulation and fraud.
- Higher risk of delisting or trading suspension.
- Lower liquidity and wider bid-ask spreads.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's intellectual property and technology.
- Review the company's legal and regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Patented polarization technology.
- Contract research service offerings.
- Focus on pharmaceutical-grade products.
- Headquartered in Burbank, California.
Preguntas Comunes Sobre QNTA
¿Cuáles son los factores clave para evaluar QNTA?
Quanta, Inc. (QNTA) actualmente tiene una puntuación IA de 50/100, indicando puntuación moderada. Fortaleza clave: Patented polarization technology.. Riesgo principal a monitorear: Potential: Intense competition from larger, more established companies in the consumer wellness market.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de QNTA?
QNTA actualmente puntúa 50/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de QNTA?
Los precios de QNTA se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre QNTA?
La cobertura de analistas para QNTA incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en QNTA?
Las categorías de riesgo para QNTA incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from larger, more established companies in the consumer wellness market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de QNTA?
La relación P/E para QNTA compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está QNTA sobrevalorada o infravalorada?
Determinar si Quanta, Inc. (QNTA) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de QNTA?
Quanta, Inc. (QNTA) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on the company's financials and operations.
- OTC listing and small market capitalization increase investment risk.
- Lack of analyst coverage and consensus.